BA.2.75: Test Detects, Differentiates Emerging Subvariant of Interest
Roche and its subsidiary TIB Molbiol have developed a COVID-19 test that detects and differentiates the latest subvariant of interest.
Read MorePosted by Chris Wolski | Aug 23, 2022 | Covid 19 |
Roche and its subsidiary TIB Molbiol have developed a COVID-19 test that detects and differentiates the latest subvariant of interest.
Read MorePosted by Chris Wolski | Aug 22, 2022 | Covid 19 |
The S-Gene dropout is a critical means for helping identify variants in SARS-CoV-2, and how they will be identified in the future.
Read MorePosted by Andy Lundin | Aug 22, 2022 | Covid 19, POC Reagents & Test Kits |
Cue Health announced that an independent clinical study demonstrated that its COVID test is as accurate as a centralized lab-based RT-PCR.
Read MorePosted by Andy Lundin | Aug 17, 2022 | Cervical (HPV), Company News |
Total Testing Solutions announced a partnership with OmniPathology to offer oral HPV testing in the Los Angeles area.
Read MorePosted by Andy Lundin | Aug 17, 2022 | Diabetes & Metabolic Diseases |
A new study estimates that the number of undiagnosed diabetes cases in the U.S. is significantly lower than current estimates suggest.
Read More